Cargando…

Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming

INTRODUCTION: Vascular leakage plays a vital role in sepsis-induced multi-organ dysfunction. Currently, no specific measures are available for vascular leakage. Ferroptosis, as a recently recognized form of cell death, plays a crucial role in cell dysfunction. It is still unknown whether ferroptosis...

Descripción completa

Detalles Bibliográficos
Autores principales: She, Han, Hu, Yi, Zhou, Yuanqun, Tan, Lei, Zhu, Yu, Ma, Chunhua, Wu, Yue, Chen, Wei, Wang, Li, Zhang, Zisen, Liu, Liangming, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670891/
https://www.ncbi.nlm.nih.gov/pubmed/34916824
http://dx.doi.org/10.2147/JIR.S340420
_version_ 1784615050827268096
author She, Han
Hu, Yi
Zhou, Yuanqun
Tan, Lei
Zhu, Yu
Ma, Chunhua
Wu, Yue
Chen, Wei
Wang, Li
Zhang, Zisen
Wang, Li
Liu, Liangming
Li, Tao
author_facet She, Han
Hu, Yi
Zhou, Yuanqun
Tan, Lei
Zhu, Yu
Ma, Chunhua
Wu, Yue
Chen, Wei
Wang, Li
Zhang, Zisen
Wang, Li
Liu, Liangming
Li, Tao
author_sort She, Han
collection PubMed
description INTRODUCTION: Vascular leakage plays a vital role in sepsis-induced multi-organ dysfunction. Currently, no specific measures are available for vascular leakage. Ferroptosis, as a recently recognized form of cell death, plays a crucial role in cell dysfunction. It is still unknown whether ferroptosis participates in the occurrence of organ dysfunction following sepsis. Our previous study showed that dexmedetomidine (Dex) could alleviate sepsis-induced organ dysfunction. However, whether the mechanism is related to ferroptosis is not clear. METHODS: The publicly available datasets of septic patients were reanalyzed, and septic models in vivo and vitro by cecal ligation and puncture and lipopolysaccharide-stimulated vascular endothelial cells (VECs) were applied. The occurrence of ferroptosis in septic patients and rats was observed, and the protective effects of Dex on ferroptosis, and related mechanisms on regulating metabolic reprogramming and mitochondrial fission were further studied. RESULTS: The transcriptomics data of patients from the GEO database showed that ferroptosis was closely related to sepsis. Sepsis induced significant ferroptosis in VECs by metabolomics analysis. The level of lipid peroxidation was increased in VECs, and the mitochondrial cristae was decreased after sepsis. Metabolomics analysis showed that Dex activated the pentose phosphate pathway and increased glutathione in VECs via up-regulation of G6PD expression. Dex could antagonize sepsis-induced the decrease in the level of Nrf2. The Nrf2 inhibitor reversed the protective effect of Dex on ferroptosis. Further study showed that Dex significantly alleviated sepsis-induced mitochondrial over-division, improved mitochondrial function, and decreased ROS, further inhibiting the ferroptosis of VECs. Dex alleviated the permeability of vessels by reducing ferroptosis and enhanced the intercellular junction of VECs. CONCLUSION: Dex protects vascular leakage following sepsis by inhibiting ferroptosis. The mechanism is mainly related to metabolic reprogramming via Nrf2 up-regulation and inhibition of mitochondrial fission.
format Online
Article
Text
id pubmed-8670891
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86708912021-12-15 Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming She, Han Hu, Yi Zhou, Yuanqun Tan, Lei Zhu, Yu Ma, Chunhua Wu, Yue Chen, Wei Wang, Li Zhang, Zisen Wang, Li Liu, Liangming Li, Tao J Inflamm Res Original Research INTRODUCTION: Vascular leakage plays a vital role in sepsis-induced multi-organ dysfunction. Currently, no specific measures are available for vascular leakage. Ferroptosis, as a recently recognized form of cell death, plays a crucial role in cell dysfunction. It is still unknown whether ferroptosis participates in the occurrence of organ dysfunction following sepsis. Our previous study showed that dexmedetomidine (Dex) could alleviate sepsis-induced organ dysfunction. However, whether the mechanism is related to ferroptosis is not clear. METHODS: The publicly available datasets of septic patients were reanalyzed, and septic models in vivo and vitro by cecal ligation and puncture and lipopolysaccharide-stimulated vascular endothelial cells (VECs) were applied. The occurrence of ferroptosis in septic patients and rats was observed, and the protective effects of Dex on ferroptosis, and related mechanisms on regulating metabolic reprogramming and mitochondrial fission were further studied. RESULTS: The transcriptomics data of patients from the GEO database showed that ferroptosis was closely related to sepsis. Sepsis induced significant ferroptosis in VECs by metabolomics analysis. The level of lipid peroxidation was increased in VECs, and the mitochondrial cristae was decreased after sepsis. Metabolomics analysis showed that Dex activated the pentose phosphate pathway and increased glutathione in VECs via up-regulation of G6PD expression. Dex could antagonize sepsis-induced the decrease in the level of Nrf2. The Nrf2 inhibitor reversed the protective effect of Dex on ferroptosis. Further study showed that Dex significantly alleviated sepsis-induced mitochondrial over-division, improved mitochondrial function, and decreased ROS, further inhibiting the ferroptosis of VECs. Dex alleviated the permeability of vessels by reducing ferroptosis and enhanced the intercellular junction of VECs. CONCLUSION: Dex protects vascular leakage following sepsis by inhibiting ferroptosis. The mechanism is mainly related to metabolic reprogramming via Nrf2 up-regulation and inhibition of mitochondrial fission. Dove 2021-12-10 /pmc/articles/PMC8670891/ /pubmed/34916824 http://dx.doi.org/10.2147/JIR.S340420 Text en © 2021 She et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
She, Han
Hu, Yi
Zhou, Yuanqun
Tan, Lei
Zhu, Yu
Ma, Chunhua
Wu, Yue
Chen, Wei
Wang, Li
Zhang, Zisen
Wang, Li
Liu, Liangming
Li, Tao
Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
title Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
title_full Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
title_fullStr Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
title_full_unstemmed Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
title_short Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
title_sort protective effects of dexmedetomidine on sepsis-induced vascular leakage by alleviating ferroptosis via regulating metabolic reprogramming
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670891/
https://www.ncbi.nlm.nih.gov/pubmed/34916824
http://dx.doi.org/10.2147/JIR.S340420
work_keys_str_mv AT shehan protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT huyi protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT zhouyuanqun protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT tanlei protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT zhuyu protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT machunhua protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT wuyue protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT chenwei protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT wangli protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT zhangzisen protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT wangli protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT liuliangming protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming
AT litao protectiveeffectsofdexmedetomidineonsepsisinducedvascularleakagebyalleviatingferroptosisviaregulatingmetabolicreprogramming